Device Center Director Advocates Getting “Experimental” With Third-Party
This article was originally published in The Gray Sheet
Executive SummaryThe Center for Devices and Radiological Health is looking to assess how third-party and FDA review of 510(k)s compare
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.